Artykuły w czasopismach na temat „BST2/Tetherin”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 49 najlepszych artykułów w czasopismach naukowych na temat „BST2/Tetherin”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Ooi, Yaw, Mathieu Dubé i Margaret Kielian. "BST2/Tetherin Inhibition of Alphavirus Exit". Viruses 7, nr 4 (22.04.2015): 2147–67. http://dx.doi.org/10.3390/v7042147.
Pełny tekst źródłaViswanathan, Kasinath, M. Shane Smith, Daniel Malouli, Mandana Mansouri, Jay A. Nelson i Klaus Früh. "BST2/Tetherin Enhances Entry of Human Cytomegalovirus". PLoS Pathogens 7, nr 11 (3.11.2011): e1002332. http://dx.doi.org/10.1371/journal.ppat.1002332.
Pełny tekst źródłaShi, Yuhang, Sydney Simpson, Yuexuan Chen, Haley Aull, Jared Benjamin i Ruth Serra-Moreno. "Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin". PLOS Pathogens 20, nr 1 (8.01.2024): e1011912. http://dx.doi.org/10.1371/journal.ppat.1011912.
Pełny tekst źródłaZheng, Yun, Xiangqi Hao, Qingxu Zheng, Xi Lin, Xin Zhang, Weijie Zeng, Shiyue Ding, Pei Zhou i Shoujun Li. "Canine Influenza Virus is Mildly Restricted by Canine Tetherin Protein". Viruses 10, nr 10 (16.10.2018): 565. http://dx.doi.org/10.3390/v10100565.
Pełny tekst źródłaMansouri, Mandana, Kasinath Viswanathan, Janet L. Douglas, Jennie Hines, Jean Gustin, Ashlee V. Moses i Klaus Früh. "Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus". Journal of Virology 83, nr 19 (15.07.2009): 9672–81. http://dx.doi.org/10.1128/jvi.00597-09.
Pełny tekst źródłaKelly, James T., Stacey Human, Joseph Alderman, Fatoumatta Jobe, Leanne Logan, Thomas Rix, Daniel Gonçalves-Carneiro i in. "BST2/Tetherin Overexpression Modulates Morbillivirus Glycoprotein Production to Inhibit Cell–Cell Fusion". Viruses 11, nr 8 (30.07.2019): 692. http://dx.doi.org/10.3390/v11080692.
Pełny tekst źródłaZhao, Xiaojuan, Dominic Alibhai, Ting Sun, Jawad Khalil, James L. Hutchinson, Kaya Olzak, Christopher M. Williams i in. "Tetherin/BST2, a physiologically and therapeutically relevant regulator of platelet receptor signalling". Blood Advances 5, nr 7 (1.04.2021): 1884–98. http://dx.doi.org/10.1182/bloodadvances.2020003182.
Pełny tekst źródłaMiller, Katelyn D., Christine Matullo, Riley Williams, Carli B. Jones i Glenn F. Rall. "Murine BST2/tetherin promotes measles virus infection of neurons". Virology 563 (listopad 2021): 38–43. http://dx.doi.org/10.1016/j.virol.2021.08.005.
Pełny tekst źródłaDietrich, Isabelle, Margaret J. Hosie i Brian J. Willett. "The role of BST2/tetherin in feline retrovirus infection". Veterinary Immunology and Immunopathology 143, nr 3-4 (październik 2011): 255–64. http://dx.doi.org/10.1016/j.vetimm.2011.06.020.
Pełny tekst źródłaVigan, Raphaël, i Stuart J. D. Neil. "Determinants of Tetherin Antagonism in the Transmembrane Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein". Journal of Virology 84, nr 24 (6.10.2010): 12958–70. http://dx.doi.org/10.1128/jvi.01699-10.
Pełny tekst źródłaPetit, Sarah J., Caroline Blondeau i Greg J. Towers. "Analysis of the human immunodeficiency virus type 1 M group Vpu domains involved in antagonizing tetherin". Journal of General Virology 92, nr 12 (1.12.2011): 2937–48. http://dx.doi.org/10.1099/vir.0.035931-0.
Pełny tekst źródłaSneha, Patil, Urmi Shah i Seetharaman Balaji. "In Silico Insights into HIV-1 Vpu-Tetherin Interactions and Its Mutational Counterparts". Medical Sciences 7, nr 6 (22.06.2019): 74. http://dx.doi.org/10.3390/medsci7060074.
Pełny tekst źródłaArnaud, Frederick, Sarah G. Black, Lita Murphy, David J. Griffiths, Stuart J. Neil, Thomas E. Spencer i Massimo Palmarini. "Interplay between Ovine Bone Marrow Stromal Cell Antigen 2/Tetherin and Endogenous Retroviruses". Journal of Virology 84, nr 9 (24.02.2010): 4415–25. http://dx.doi.org/10.1128/jvi.00029-10.
Pełny tekst źródłaPan, Xiao-Ben, Jin-Chao Han, Xu Cong i Lai Wei. "BST2/Tetherin Inhibits Dengue Virus Release from Human Hepatoma Cells". PLoS ONE 7, nr 12 (7.12.2012): e51033. http://dx.doi.org/10.1371/journal.pone.0051033.
Pełny tekst źródłaHolmgren, Alicia M., Katelyn D. Miller, Sarah E. Cavanaugh i Glenn F. Rall. "Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge". Journal of Virology 89, nr 21 (26.08.2015): 11011–18. http://dx.doi.org/10.1128/jvi.01745-15.
Pełny tekst źródłaPetrosino, Maria, Francesco Stellato, Roberta Chiaraluce, Valerio Consalvi, Giovanni La Penna, Alessandra Pasquo, Olivier Proux, Giancarlo Rossi i Silvia Morante. "Zn‐Induced Interactions Between SARS‐CoV‐2 orf7a and BST2/Tetherin". ChemistryOpen 10, nr 11 (listopad 2021): 1133–41. http://dx.doi.org/10.1002/open.202100217.
Pełny tekst źródłaPan, Xiao-Ben, Xiao-Wang Qu, Dong Jiang, Xing-Liang Zhao, Jin-Chao Han i Lai Wei. "BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells". Antiviral Research 98, nr 1 (kwiecień 2013): 54–60. http://dx.doi.org/10.1016/j.antiviral.2013.01.009.
Pełny tekst źródłaBego, Mariana G., Lijun Cong, Katharina Mack, Frank Kirchhoff i Éric A. Cohen. "Differential Control of BST2 Restriction and Plasmacytoid Dendritic Cell Antiviral Response by Antagonists Encoded by HIV-1 Group M and O Strains". Journal of Virology 90, nr 22 (31.08.2016): 10236–46. http://dx.doi.org/10.1128/jvi.01131-16.
Pełny tekst źródłaStrauss, Joshua D., Jason E. Hammonds, Hong Yi, Lingmei Ding, Paul Spearman i Elizabeth R. Wright. "Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells". Journal of Virology 90, nr 3 (18.11.2015): 1507–21. http://dx.doi.org/10.1128/jvi.01880-15.
Pełny tekst źródłaPan, X. B., J. H. Chang, T. M. Block i J. T. Guo. "PP-145 BST2/Tetherin inhibits hepatitis C virus release from human hepatoma cells". International Journal of Infectious Diseases 15 (lipiec 2011): S85—S86. http://dx.doi.org/10.1016/s1201-9712(11)60297-x.
Pełny tekst źródłaPresle, Adrien, Stéphane Frémont, Audrey Salles, Pierre-Henri Commere, Nathalie Sassoon, Clarisse Berlioz-Torrent, Neetu Gupta-Rossi i Arnaud Echard. "The viral restriction factor tetherin/BST2 tethers cytokinetic midbody remnants to the cell surface". Current Biology 31, nr 10 (maj 2021): 2203–13. http://dx.doi.org/10.1016/j.cub.2021.02.039.
Pełny tekst źródłaSauter, Daniel, Michael Vogl i Frank Kirchhoff. "Ancient origin of a deletion in human BST2/Tetherin that confers protection against viral zoonoses". Human Mutation 32, nr 11 (11.08.2011): 1243–45. http://dx.doi.org/10.1002/humu.21571.
Pełny tekst źródłaJanvier, Katy, Nicolas Roy i Clarisse Berlioz-Torrent. "Role of the Endosomal ESCRT Machinery in HIV-1 Vpu-Induced Down- Regulation of BST2/Tetherin". Current HIV Research 10, nr 4 (1.05.2012): 315–20. http://dx.doi.org/10.2174/157016212800792414.
Pełny tekst źródłaSwiecki, Melissa, Yaming Wang, Susan Gilfillan, Deborah J. Lenschow i Marco Colonna. "Cutting Edge: Paradoxical Roles of BST2/Tetherin in Promoting Type I IFN Response and Viral Infection". Journal of Immunology 188, nr 6 (10.02.2012): 2488–92. http://dx.doi.org/10.4049/jimmunol.1103145.
Pełny tekst źródłaSchubert, H. L., Q. Zhai, V. Sandrin, D. M. Eckert, M. Garcia-Maya, L. Saul, W. I. Sundquist, R. A. Steiner i C. P. Hill. "Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations". Proceedings of the National Academy of Sciences 107, nr 42 (29.09.2010): 17951–56. http://dx.doi.org/10.1073/pnas.1008206107.
Pełny tekst źródłaJia, Bin, Ruth Serra-Moreno, William Neidermyer, Andrew Rahmberg, John Mackey, Ismael Ben Fofana, Welkin E. Johnson, Susan Westmoreland i David T. Evans. "Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2". PLoS Pathogens 5, nr 5 (15.05.2009): e1000429. http://dx.doi.org/10.1371/journal.ppat.1000429.
Pełny tekst źródłaEpeldegui, Marta, Bianca Blom i Christel H. Uittenbogaart. "BST2/Tetherin is constitutively expressed on human thymocytes with the phenotype and function of Treg cells". European Journal of Immunology 45, nr 3 (16.12.2014): 728–37. http://dx.doi.org/10.1002/eji.201444787.
Pełny tekst źródłaSantos, Rodrigo I., Philipp A. Ilinykh, Colette A. Pietzsch, Adam J. Ronk, Kai Huang, Natalia A. Kuzmina, Fuchun Zhou, James E. Crowe i Alexander Bukreyev. "Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin". Cell Reports 42, nr 10 (październik 2023): 113254. http://dx.doi.org/10.1016/j.celrep.2023.113254.
Pełny tekst źródłaMatatall, Katie A., Hamilton Wang, Roman Jaksik, Marek Kimmel, Dongsu Park i Katherine Y. King. "A Novel Role for Bst2 and E-Selectin in IFNg-Stimulated HSC Niche Relocalization". Blood 132, Supplement 1 (29.11.2018): 874. http://dx.doi.org/10.1182/blood-2018-99-116547.
Pełny tekst źródłaJaguva Vasudevan, Ananda Ayyappan, Daniel Becker, Tom Luedde, Holger Gohlke i Carsten Münk. "Foamy Viruses, Bet, and APOBEC3 Restriction". Viruses 13, nr 3 (18.03.2021): 504. http://dx.doi.org/10.3390/v13030504.
Pełny tekst źródłaHammonds, Jason, Jaang-Jiun Wang, Hong Yi i Paul Spearman. "Immunoelectron Microscopic Evidence for Tetherin/BST2 as the Physical Bridge between HIV-1 Virions and the Plasma Membrane". PLoS Pathogens 6, nr 2 (5.02.2010): e1000749. http://dx.doi.org/10.1371/journal.ppat.1000749.
Pełny tekst źródłaPaliwal, Daizy, Prashant Joshi i Subrat Kumar Panda. "Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR". PLOS ONE 12, nr 11 (1.11.2017): e0187334. http://dx.doi.org/10.1371/journal.pone.0187334.
Pełny tekst źródłaSayeed, Aejaz, Gloria Luciani-Torres, Zhenhang Meng, James L. Bennington, Dan H. Moore i Shanaz H. Dairkee. "Aberrant Regulation of the BST2 (Tetherin) Promoter Enhances Cell Proliferation and Apoptosis Evasion in High Grade Breast Cancer Cells". PLoS ONE 8, nr 6 (20.06.2013): e67191. http://dx.doi.org/10.1371/journal.pone.0067191.
Pełny tekst źródłaGustin, Jean K., Ying Bai, Ashlee V. Moses i Janet L. Douglas. "Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin". Journal of Infectious Diseases 212, suppl 2 (27.03.2015): S181—S190. http://dx.doi.org/10.1093/infdis/jiv125.
Pełny tekst źródłaMadjo, Ursula, Olivier Leymarie, Stéphane Frémont, Aurelia Kuster, Mélanie Nehlich, Sarah Gallois-Montbrun, Katy Janvier i Clarisse Berlioz-Torrent. "LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway". Cell Reports 17, nr 9 (listopad 2016): 2221–33. http://dx.doi.org/10.1016/j.celrep.2016.10.045.
Pełny tekst źródłaPham, T. N. Q., S. Lukhele i É. A. Cohen. "OA2-4 Enhancing HIV-1 virion tethering by BST2/tetherin sensitizes productively and latently infected T cells to ADCC mediated by broadly neutralizing anti-HIV antibodies". Journal of Virus Eradication 2 (lipiec 2016): 3. http://dx.doi.org/10.1016/s2055-6640(20)31011-6.
Pełny tekst źródłaMwimanzi, Philip, Ian Tietjen, Scott C. Miller, Aniqa Shahid, Kyle Cobarrubias, Natalie N. Kinloch, Bemuluyigza Baraki i in. "Novel Acylguanidine-Based Inhibitor of HIV-1". Journal of Virology 90, nr 20 (10.08.2016): 9495–508. http://dx.doi.org/10.1128/jvi.01107-16.
Pełny tekst źródłaMurphy, Lita, Mariana Varela, Sophie Desloire, Najate Ftaich, Claudio Murgia, Matthew Golder, Stuart Neil i in. "The Sheep Tetherin Paralog oBST2B Blocks Envelope Glycoprotein Incorporation into Nascent Retroviral Virions". Journal of Virology 89, nr 1 (22.10.2014): 535–44. http://dx.doi.org/10.1128/jvi.02751-14.
Pełny tekst źródłaTanwattana, Nathiphat, Nanchaya Wanasen, Yuparat Jantraphakorn, Kanjana Srisutthisamphan, Thanathom Chailungkarn, Suwimon Boonrungsiman, Boonlert Lumlertdacha, Porntippa Lekchareonsuk i Challika Kaewborisuth. "Human BST2 inhibits rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation". PLOS ONE 18, nr 11 (3.11.2023): e0292833. http://dx.doi.org/10.1371/journal.pone.0292833.
Pełny tekst źródłaZhao, Yifei, Ke Zhao, Shaohua Wang i Juan Du. "Multi-functional BST2/tetherin against HIV-1, other viruses and LINE-1". Frontiers in Cellular and Infection Microbiology 12 (13.09.2022). http://dx.doi.org/10.3389/fcimb.2022.979091.
Pełny tekst źródłaJia, Xiaofei, Erin Weber, Andrey Tokarev, Mary Lewinski, Maryan Rizk, Marissa Suarez, John Guatelli i Yong Xiong. "Structural basis of HIV-1 Vpu-mediated BST2 antagonism via hijacking of the clathrin adaptor protein complex 1". eLife 3 (29.04.2014). http://dx.doi.org/10.7554/elife.02362.
Pełny tekst źródłaJudith, Delphine, Margaux Versapuech, Fabienne Bejjani, Marjory Palaric, Pauline Verlhac, Aurelia Kuster, Leslie Lepont, Sarah Gallois-Montbrun, Katy Janvier i Clarisse Berlioz-Torrent. "ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway". Proceedings of the National Academy of Sciences 120, nr 20 (8.05.2023). http://dx.doi.org/10.1073/pnas.2217451120.
Pełny tekst źródłaDolskiy, Alexander A., Sergei A. Bodnev, Anastasia A. Nazarenko, Anastasia M. Smirnova, Olga G. Pyankova, Anna K. Matveeva, Irina V. Grishchenko i in. "Deletion of BST2 Cytoplasmic and Transmembrane N-Terminal Domains Results in SARS-CoV, SARS-CoV-2, and Influenza Virus Production Suppression in a Vero Cell Line". Frontiers in Molecular Biosciences 7 (18.12.2020). http://dx.doi.org/10.3389/fmolb.2020.616798.
Pełny tekst źródłaBotticelli, S., R. Chiaraluce, V. Consalvi, G. La Penna, A. Pasquo, M. Petrosino, O. Proux, G. C. Rossi, F. Stellato i S. Morante. "The role of Zn ions in the interaction between SARS-CoV-2 orf7a protein and BST2/tetherin". European Physical Journal Plus 138, nr 3 (8.03.2023). http://dx.doi.org/10.1140/epjp/s13360-023-03731-w.
Pełny tekst źródłaLiberatore, Rachel A., Emily J. Mastrocola, Chelsea Powell i Paul D. Bieniasz. "Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis". Journal of Virology 91, nr 12 (5.04.2017). http://dx.doi.org/10.1128/jvi.02286-16.
Pełny tekst źródłaRizk, Maryan G., Christopher F. Basler i John Guatelli. "Cooperation of the Ebola Virus Proteins VP40 and GP1,2 with BST2 To Activate NF-κB Independently of Virus-Like Particle Trapping". Journal of Virology 91, nr 22 (6.09.2017). http://dx.doi.org/10.1128/jvi.01308-17.
Pełny tekst źródłaBarriocanal, Marina, Elena Carnero, Victor Segura i Puri Fortes. "Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin". Frontiers in Immunology 5 (9.01.2015). http://dx.doi.org/10.3389/fimmu.2014.00655.
Pełny tekst źródłaOhAinle, Molly, Louisa Helms, Jolien Vermeire, Ferdinand Roesch, Daryl Humes, Ryan Basom, Jeffrey J. Delrow, Julie Overbaugh i Michael Emerman. "A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV". eLife 7 (6.12.2018). http://dx.doi.org/10.7554/elife.39823.
Pełny tekst źródłaShi, Yuhang, Sergio Castro-Gonzalez, Yuexuan Chen i Ruth Serra-Moreno. "Effects of the SUMO Ligase BCA2 on Metabolic Activity, Cell Proliferation, Cell Migration, Cell Cycle, and the Regulation of NF-κB and IRF1 in Different Breast Epithelial Cellular Contexts". Frontiers in Cell and Developmental Biology 9 (13.09.2021). http://dx.doi.org/10.3389/fcell.2021.711481.
Pełny tekst źródła